OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!
If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.
Requested Article:
Breaking the ‘Undruggable’ Barrier: Anti-PD-1/PD-L1 Immunotherapy for Non-Small Cell Lung Cancer Patients with KRAS Mutations—A Comprehensive Review and Description of Single Site Experience
Izabela Chmielewska, Paweł Krawczyk, Anna Grenda, et al.
Cancers (2023) Vol. 15, Iss. 14, pp. 3732-3732
Open Access | Times Cited: 5
Izabela Chmielewska, Paweł Krawczyk, Anna Grenda, et al.
Cancers (2023) Vol. 15, Iss. 14, pp. 3732-3732
Open Access | Times Cited: 5
Showing 5 citing articles:
Intersecting evidence: Bibliometric analysis and clinical trials illuminate immunotherapy in KRAS-mutation cancer: A review
Hongyang Liu, Min Qiang, Ying Zhang, et al.
Medicine (2024) Vol. 103, Iss. 36, pp. e39334-e39334
Open Access
Hongyang Liu, Min Qiang, Ying Zhang, et al.
Medicine (2024) Vol. 103, Iss. 36, pp. e39334-e39334
Open Access
Current Understanding on Impact of Kirsten Rat Sarcoma Viral Oncogene Mutation on Colorectal Cancer: A Review
Shampa Pakhira, Priya Samanta, Rituparna Ghosh, et al.
(2024) Vol. 1, Iss. 1, pp. 8-13
Closed Access
Shampa Pakhira, Priya Samanta, Rituparna Ghosh, et al.
(2024) Vol. 1, Iss. 1, pp. 8-13
Closed Access
eIF4A dependency: the hidden key to unlock KRAS mutant non-small cell lung cancer’s vulnerability
Sílvia Casacuberta‐Serra, Í. González-Larreategui, Laura Soucek
Translational Lung Cancer Research (2023) Vol. 12, Iss. 12, pp. 2570-2575
Open Access | Times Cited: 1
Sílvia Casacuberta‐Serra, Í. González-Larreategui, Laura Soucek
Translational Lung Cancer Research (2023) Vol. 12, Iss. 12, pp. 2570-2575
Open Access | Times Cited: 1
KRAS-Degrading Compounds: A Novel Approach to Treat Cancer by Targeting Both Wild-Type and Mutated KRAS Forms
Robert B. Kargbo
ACS Medicinal Chemistry Letters (2023) Vol. 14, Iss. 11, pp. 1493-1495
Closed Access
Robert B. Kargbo
ACS Medicinal Chemistry Letters (2023) Vol. 14, Iss. 11, pp. 1493-1495
Closed Access
Sotorasib for non-small cell lung cancer — current options and perspectives
Magdalena Knetki‐Wróblewska, Bartosz Wasąg
Oncology in Clinical Practice (2023) Vol. 20, Iss. 3, pp. 215-221
Open Access
Magdalena Knetki‐Wróblewska, Bartosz Wasąg
Oncology in Clinical Practice (2023) Vol. 20, Iss. 3, pp. 215-221
Open Access
